|


The Royal Society of Chemistry 9 May 2006 - High Throughput Medicinal Chemistry
    
High throughput techniques have revolutionised the drug discovery process and are widely used in medicinal
chemistry to speed the development of new and higher quality drug candidates. The scientific programme of
the "High Throughput Medicinal Chemistry" meeting will include presentations on computational tools,
purification of small organic molecules, ADME , fragment based design and case studies from GlaxoSmithKline,
AstraZeneca and Merck Sharpe and Dohme.
Date: |
9 May 2006 |
Location: |
Institute of Physics, 76 Portland Place, London |
Application and Fees: |
|
For Further Information: |
Please contact Michele Sahrle. |
|
 |
 |
09:00 |
Registration and Coffee |
09:50 |
Introduction |
10:00 |
High Throughput Medicinal Chemistry - A Comparison of Computational Methods Colin Edge, GlaxoSmithKline |
10:40 |
Fluorous Mixture Synthesis Approaches to Natural Product Stereoisomer Libraries Dennis Curran, University of Pittsburgh |
11:20 |
Dealing From a Crooked Deck: The Card-Shark's Guide to High-Throughput Screening Trevor Perrior, NCE Discovery |
12:00 |
Lunch |
13:00 |
The Application of High Throughput Technologies in Solid Form Development Chris Frampton, Pharmorphix |
13:40 |
Enabling HTS Hit Follow up via Chemoinformatics, File-Enrichment and Outsourcing Graham Smith, Pfizer |
14:20 |
Expedite Hit Discovery: Split & Pool in the 21st Century Andreas Marzinzik, Novartis |
15:00 |
Tea and Coffee |
15:40 |
Agrochemical Lead Generation using Solid and Solution Phase HTS Mike Robson, Syngenta |
16:20 |
High Throughput Chemistry in Drug Discovery. Success or Sophistry? Peter Machin, GlaxoSmithKline |
17:00 |
Wine Reception |
19:00 |
finish |
|
|
 |
 |
|